Eric G. Barcenas-Salmeron

Mexico, MEX 07360, Mexico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

miR-19a-3p as a Candidate oncomiRNA in Cervical Cancer: Insights From a Bioinformatic Analysis.

miR-19a-3p as a Candidate oncomiRNA in Cervical Cancer: Insights From a Bioinformatic Analysis.

Journal: Frontiers in bioscience (Landmark edition)

Published: February 25, 2026

MicroRNAs Let-7b-5p and miR-24-3p as Potential Therapeutic Agents Targeting Pancreatic Cancer Stem Cells.

MicroRNAs Let-7b-5p and miR-24-3p as Potential Therapeutic Agents Targeting Pancreatic Cancer Stem Cells.

Journal: International journal of molecular sciences

Published: October 14, 2025

DNMT Enzymes and Their Impact on Cervical Cancer: A State-of-the-Art Review.

DNMT Enzymes and Their Impact on Cervical Cancer: A State-of-the-Art Review.

Journal: International journal of molecular sciences

Published: October 01, 2025

Let-7c/RUNX1 Axis Promotes Cervical Cancer: A Bioinformatic Analysis.

Let-7c/RUNX1 Axis Promotes Cervical Cancer: A Bioinformatic Analysis.

Journal: Current issues in molecular biology

Published: July 25, 2025

Exometabolome and Molecular Signatures Associated with HPV 16 in Cervical Cancer: Integrative Metabolomic and Transcriptomic Analysis for Biomarker Discovery.

Exometabolome and Molecular Signatures Associated with HPV 16 in Cervical Cancer: Integrative Metabolomic and Transcriptomic Analysis for Biomarker Discovery.

Journal: Molecules (Basel, Switzerland)

Published: July 24, 2025

Expression of Oct3/4 isoforms and its association with the risk of relapse in acute lymphoblastic leukemia.

Expression of Oct3/4 isoforms and its association with the risk of relapse in acute lymphoblastic leukemia.

Journal: Biomedical reports

Published: December 16, 2024

Bioinformatics Analysis Reveals E6 and E7 of HPV 16 Regulate Metabolic Reprogramming in Cervical Cancer, Head and Neck Cancer, and Colorectal Cancer through the PHD2-VHL-CUL2-ELOC-HIF-1α Axis.

Bioinformatics Analysis Reveals E6 and E7 of HPV 16 Regulate Metabolic Reprogramming in Cervical Cancer, Head and Neck Cancer, and Colorectal Cancer through the PHD2-VHL-CUL2-ELOC-HIF-1α Axis.

Journal: Current issues in molecular biology

Published: May 02, 2024

TET enzymes and 5hmC epigenetic mark: new key players in carcinogenesis and progression in gynecological cancers.

TET enzymes and 5hmC epigenetic mark: new key players in carcinogenesis and progression in gynecological cancers.

Journal: European review for medical and pharmacological sciences

Published: February 20, 2024

TET Enzymes and 5hmC Levels in Carcinogenesis and Progression of Breast Cancer: Potential Therapeutic Targets.

TET Enzymes and 5hmC Levels in Carcinogenesis and Progression of Breast Cancer: Potential Therapeutic Targets.

Journal: International journal of molecular sciences

Published: November 24, 2023

Circulating miRNAs as Noninvasive Biomarkers for PDAC Diagnosis and Prognosis in Mexico.

Circulating miRNAs as Noninvasive Biomarkers for PDAC Diagnosis and Prognosis in Mexico.

Journal: International journal of molecular sciences

Published: August 09, 2023

Identification of Mir-182-3p/FLI-1 Axis as a Key Signaling in Immune Response in Cervical Cancer: A Comprehensive Bioinformatic Analysis.

Identification of Mir-182-3p/FLI-1 Axis as a Key Signaling in Immune Response in Cervical Cancer: A Comprehensive Bioinformatic Analysis.

Journal: International journal of molecular sciences

Published: February 02, 2023

Expression of HIF-1α and Genes Involved in Glucose Metabolism Is Increased in Cervical Cancer and HPV-16-Positive Cell Lines.

Expression of HIF-1α and Genes Involved in Glucose Metabolism Is Increased in Cervical Cancer and HPV-16-Positive Cell Lines.

Journal: Pathogens (Basel, Switzerland)

Published: November 14, 2022

Showing 1-12 of 21

Last Updated: 09/26/2026